Fred Alger Management’s Allergan plc AGN.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,255
Closed -$736K 609
2017
Q4
$736K Sell
1,255
-143
-10% -$92.3K ﹤0.01% 351
2017
Q3
$1.03M Sell
1,398
-33
-2% -$27.4K ﹤0.01% 324
2017
Q2
$1.24M Hold
1,431
0.01% 321
2017
Q1
$1.21M Hold
1,431
0.01% 316
2016
Q4
$1.09M Hold
1,431
0.01% 286
2016
Q3
$1.18M Hold
1,431
0.01% 298
2016
Q2
$1.19M Hold
1,431
0.01% 315
2016
Q1
$1.31M Sell
1,431
-20
-1% -$19.1K 0.01% 355
2015
Q4
$1.49M Buy
+1,451
New +$1.46M 0.01% 352
2015
Q3
Sell
-1,501
Closed -$1.57M 529
2015
Q2
$1.57M Buy
+1,501
New +$1.57M 0.01% 402

Other funds holding AGN.PRA

Fred Alger Management's AGN.PRA Position: Q1 2018 in Review

Fred Alger Management sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 1,255 shares — an estimated $736K sold.

Fred Alger Management first reported a position in AGN.PRA in Q2 2015 and held it in 10 quarters. The position peaked at $1.57M in Q2 2015. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

  • Fred Alger Management reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Fred Alger Management sold 1,255 Allergan plc shares in Q1 2018, an estimated $736K.
  • Fred Alger Management first reported a position in Allergan plc in Q2 2015 and held it in 10 quarters.
  • Fred Alger Management's Allergan plc position peaked at $1.57M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Fred Alger Management's 13F filing for Q1 2018, filed 10 May 2018.